Skip to main content
Premium Trial:

Request an Annual Quote

Geospiza Reels in SBIR Grant

NEW YORK (GenomeWeb News) - Geospiza has won a Small Business Innovation Research grant from the National Human Genome Research Institute to fund genomic analysis software development, the company said today.

The Seattle-based company plans to use the Phase I grant to develop software that will be used in detecting rare mutations found in certain cancer types and to help make treatment decisions.

"New sequencing technologies are advancing at a significant pace and the instrument vendors are making tremendous progress in developing a wide range of applications that will change how we examine gene expression and study how variations in DNA sequences cause disease and impact health," Geospiza CSO Todd Smith said in a statement.

"This award will help us conduct important research to develop new methods to support resequencing applications," he added.

Geospiza did not disclose the amount of the grant, but standard Phase I SBIR awards last up to six months and grant as much as $100,000.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.